Showing 941 - 945 results of 945 for search '"LIAT"', query time: 0.09s Refine Results
  1. 941
  2. 942

    A thorough QT study to assess the effects of tbo-filgrastim on cardiac repolarization in healthy subjects by Adar L, Avisar N, Lammerich A, Kleiman RB, Spiegelstein O

    Published 2015-05-01
    “…Liat Adar,1 Noa Avisar,1 Andreas Lammerich,2 Robert B Kleiman,3 Ofer Spiegelstein1 1R&D, Teva Pharmaceutical Industries Ltd, Netanya, Israel; 2Biosimilars Clinical Development, CPP Teva ratiopharm, Merckle GmbH, Ulm, Germany; 3Global Cardiology, eResearch Technology Inc, Philadelphia, PA, USA Abstract: Tbo-filgrastim is a recombinant human granulocyte colony-stimulating factor approved by the US Food and Drug Administration to reduce the duration of severe neutropenia in patients with nonmyeloid malignancies receiving myelosuppressive anticancer drugs associated with a clinically significant incidence of febrile neutropenia. …”
    Get full text
    Article
  3. 943
  4. 944
  5. 945

    Supply Chain Management Performance of HIV/AIDS Commodities and Factors Affecting It at Health Facilities of SNNPRS of Ethiopia; from the Perspective of Achieving 90-90-90 Strategi... by Damtie TA, Ibrahim AJ, Yikna BB

    Published 2020-01-01
    “…Semi-structured questionnaires and observation checklists with logistic indicators assessment tools (LIATs) were used to collect data for HIV/AIDS related services from November 2016 to May 2017. …”
    Get full text
    Article